|
Guideline or local working group recommendation
|
Number of respondents consulting for treatment n (%)a
|
|---|
| |
France
|
Germany
|
Italy
|
Spain
|
UK
|
Total
|
|---|
|
N = 15
|
N = 15
|
N = 15
|
N = 15
|
N = 15
|
N = 75
|
|---|
|
ASH/ASCO, US
|
9 (60)
|
3 (20)
|
7 (47)
|
6 (40)
|
4 (27)
|
29 (39)
|
|
EWALL, Europe
|
7 (47)
|
1 (7)
|
2 (13)
|
2 (13)
|
7 (47)
|
19 (25)
|
|
NCCN, US
|
6 (40)
|
1 (7)
|
5 (33)
|
5 (33)
| |
17 (23)
|
|
GMALL, Germany
|
1 (7)
|
13 (60)
|
1 (7)
|
1 (7)
| |
16 (21)
|
|
GIMEMA, Italy
| | |
12 (80)
|
1 (7)
| |
13 (17)
|
|
PETHEMA, Spain
| | | |
11 (73)
|
1 (7)
|
12 (16)
|
|
UKALL XII, UK
| | |
1 (7)
| |
11 (73)
|
12 (16)
|
|
HAS, France
|
2 (13)
| | | | |
2 (3)
|
|
Othersb
|
4 (27)
| | | |
3 (20)
|
7 (9)
|
- aRespondents could select multiple guidelines
- bThe following guidelines and/or local working group recommendations were consulted by one respondent for treatment: COOPRALL, France; Onco LR, France; GELA, France; GRAALL, France; BCSH, UK; The Beatson hospital, UKc; UKALL 2011 for young adults, UK; non-specified protocol
- cThe Beatson hospital is a cancer centre located in the West of Scotland
- ALL, acute lymphoblastic leukaemia; ASCO, American Society of Clinical Oncology; ASH, American Society of Hematology; BCSH, the British Committee for Standards in Haematology; COOPRALL, Protocole Coopérateur de Traitement des Rechutes de Leucémies Aiguës Lymphoblastiques de L’enfant (treatment protocol for relapse of ALL in children); EWALL, European Working group for Adult Lymphoblastic Leukemia; GELA, Groupe d’Etude des Lymphomes de l’Adulte (Study Group of the Adult Lymphoma); GET-LALA, Groupe d’Etude et de Traitement des Leucémie Aiguës Lymphoblastique de l’Adulte (Group for the Study and Treatment of Adult ALL, France); GIMEMA, Gruppo Italiano Malattie EMatologiche dell’Adultodell’Adulto (Italian Group for Haematological Diseases in Adults); GMALL, German Multicenter Study Group for Adult ALL; GOELAMS, Groupe Ouest Est des Leucémies Aiguës et Maladies du Sang (East West Group of Acute Leukemia and Blood Diseases, France); GRAALL, Cooperative group combining the French GET-LALA, the GOELAMS, and the SAKK; HAS, Haute Autorité de Santé (High Authority for Health); NCCN, the National Comprehensive Cancer Network; Onco LR, le réseau régional de Cancérologie en Languedoc Roussillon (regional network of Oncology in Languedoc Roussillon); PETHEMA, Program for Study and Treatment of Malignant Haemopathies, Spanish Society of Haematology; SAKK, Schweizer Arbeitsgemeinschaft für klinische Krebsforschung, Leukämie-Arbeitsgruppe (Swiss Group for Clinical Cancer Research, Leukemia Working Group); UKALL 2011 for young adults, United Kingdom Trial for children and young adults with Acute lymphoblastic Leukaemia and Lymphoma 2011; UKALL XII, Medical Research Council Acute Lymphoblastic Leukemia Trial XII
